Monday, November 25, 2024

NEWS

NEWS

Uzbekistan and China will produce anti-SARS-COV-2 coronavirus vaccine

Tashkent, Aug 12 (Prensa Latina) Chinese biopharmaceutical company Anhui Zhifei Longcom and Uzbek Jurabek Laboratories announced today the signing of an agreement for the purchase and production in this country of Chinese vaccines against Covid-19.

August 12, 2021
09:54

The Uzbek company has prepared a separate line for the production of the Anhui Zhifei Longkom Biopharmaceutical vaccine, which has already been audited by Chinese experts, TASS news agency reported.

It is expected that in the near future a series will be developed for the validation of the vaccine, after which its production will be authorized.

The drug to be developed in Uzbekistan will be obtained by producing the recombining protein NCP-RBD from SARS-CoV-2 coronavirus.

pgh/lcp

#Uzbekistan China vaccine production

11:10

Cuba laments insufficient COP29 results

10:54

Syrian FM and UN envoy address aggressive Israeli escalation

10:49

Millions of poors in the U.S. did not vote

10:43

World’s oldest alphabet discovered in Syria

10:42

European meeting of solidarity with Cuba described as a success

10:37

Lebanese army confirms casualties from Israeli strike

Cuba laments insufficient COP29 results

November 24, 2024
11:10 am

Syrian FM and UN envoy address aggressive Israeli escalation

November 24, 2024
10:54 am

Millions of poors in the U.S. did not vote

November 24, 2024
10:49 am

World’s oldest alphabet discovered in Syria

November 24, 2024
10:43 am

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.